Mycophenolate mofetil in systemic sclerosis-associated interstitial lung disease

Author： Koutroumpas Athanasios   Ziogas Athanasios   Alexiou Ioannis   Barouta Georgia   Sakkas Lazaros  

Publisher： Springer Publishing Company

ISSN： 0770-3198

Source： Clinical Rheumatology, Vol.29, Iss.10, 2010-10, pp. : 1167-1168

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Systemic Sclerosis-Associated Interstitial Lung Disease: Lessons from Clinical Trials, Outcome Measures, and Future Study Design

By  

Current Rheumatology Reviews, Vol. 6, Iss. 2, 2010-05 ,pp. : 138-144

Bentham Science Publishers

Access to resources Recommend Favorite

Systemic Sclerosis Associated Interstitial Lung Disease

By  

Current Respiratory Medicine Reviews, Vol. 11, Iss. 2, 2015-01 ,pp. : 110-118

Bentham Science Publishers

Access to resources Recommend Favorite

Systemic Sclerosis Associated Interstitial Lung Disease

By  

Current Respiratory Medicine Reviews, Vol. 11, Iss. 2, 2015-08 ,pp. : 110-118

Bentham Science Publishers

Access to resources Recommend Favorite

Interstitial Lung Disease in Systemic Sclerosis

By Ostojic Predrag   Cerinic Marco   Silver Richard   Highland Kristin   Damjanov Nemanja  

Lung, Vol. 185, Iss. 4, 2007-08 ,pp. : 211-220

Springer Publishing Company

Access to resources Recommend Favorite

Experience with azathioprine in systemic sclerosis associated with interstitial lung disease

By Dheda K.   Lalloo U.   Cassim B.   Mody G.  

Clinical Rheumatology, Vol. 23, Iss. 4, 2004-08 ,pp. : 306-309

Springer Publishing Company

Access to resources Recommend Favorite